Gliclavac MR 30 Tablet
Marketer
Prevego Healthcare & Research Private Limited
Salt Composition
Gliclazide (30mg)
Overview Gliclavac MR 30 Tablet
Diabetic patients aged 18 and over may be prescribed Gliclavac MR 30 to manage type 2 diabetes. This sulfonylurea medication regulates blood glucose, mitigating risks such as vision impairment and renal complications. Gliclavac MR 30 may be used independently or in conjunction with other therapies and should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on individual response. Continuous use is crucial; abrupt cessation, without medical supervision, elevates the risk of hyperglycemia, potentially leading to neuropathy, nephropathy, and limb loss. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your healthcare provider. Common adverse effects include gastrointestinal discomfort and hypoglycemia. Recognizing hypoglycemic symptoms (tremors, sweating, dizziness, headaches) and having readily available glucose (e.g., juice, candy) is essential. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Weight gain is a possible side effect. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart, thyroid, or endocrine disorders should be disclosed to your physician before initiating treatment. Pregnant or lactating individuals require medical consultation before commencing Gliclavac MR 30 therapy. Regular blood glucose monitoring and periodic blood tests (complete blood count and liver function tests) are recommended.
Uses of Gliclavac MR 30 Tablet
Managing type 2 diabetes
Major Benefits of Gliclavac MR 30 Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Gliclavac MR 30 Tablet should be administered with a meal.
Common Side effects of Gliclavac MR 30 Tablet:
- Hypoglycemia (low blood glucose level)
- Weight gain
- Flatulence
- Diarrhea
- Headache
- Nausea
- Dizziness
How to use Gliclavac MR 30 Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Gliclavac MR 30 Tablet with a meal.
How Gliclavac MR 30 Tablet works:
This drug treats diabetes by stimulating pancreatic insulin secretion, thereby reducing blood glucose.
SAFETY ADVICE
AlcoholUNSAFE
Avoid alcohol consumption while taking Gliclavac MR 30 Tablets.
PregnancyCONSULT YOUR DOCTOR
The use of Gliclavac MR 30 Tablet during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against any risks prior to prescribing. Consult your doctor for advice.
Breast feedingUNSAFE
Lactation is contraindicated with Gliclavac MR 30 Tablets due to the potential for infant toxicity.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneySAFE IF PRESCRIBED
Gliclavac MR 30 Tablets are considered safe for use in individuals with kidney impairment; no alteration in dosage is advised. Nevertheless, this medication is prohibited for patients exhibiting severe kidney dysfunction.
LiverCAUTION
Patients with severe hepatic impairment should exercise caution when using Gliclavac MR 30 Tablet; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Gliclavac MR 30 Tablet :
Should you forget a dose of Gliclavac MR 30 Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Gliclavac MR 30 Tablet
| Label | Value |
|---|---|
| Chemical Type | Improved sulfonylurea |
| Developing Habits | No. |
| Treatment Category | Diabetes Medication |
| Behavior Class | Insulin-Stimulating Sulfonylureas |



